Swiss-listed BB Biotech celebrates 30 years of outperformance with fund manager Dr Daniel Koller confident the biotechnology slump of the past two years will in time look like a small setback.
Information
- Show
- FrequencyMonthly
- Published1 December 2023 at 14:37 UTC
- Length41 min
- RatingClean